SCHEMBL459199

SCHEMBL459199

Cc1ccc(F)c(C(CO)[N+](=O)[O-])c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.40
TSHR P16473 4/20 0.36
CYP3A4 P08684 1/20 0.36
LMNA P02545 3/20 0.36
RECQL P46063 1/20 0.36
PSEN1 P49768 1/20 0.35
PSEN2 P49810 1/20 0.35
APH1B Q8WW43 1/20 0.35
NCSTN Q92542 1/20 0.35
APH1A Q96BI3 1/20 0.35
PSENEN Q9NZ42 1/20 0.35
RAB9A P51151 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
ALDH1A1 P00352 2/20 0.33
KAT2B Q92831 2/20 0.32
CA1 P00915 1/20 0.32
MMP2 P08253 1/20 0.32
CA14 Q9ULX7 1/20 0.32
ACHE P22303 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1444104 0.84 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL458881 0.83 MEN1 (0.30) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL14722721 0.78
SCHEMBL6128210 0.77 CES2 (0.39) TSHRCYP3A4RAB9AMEN1KMT2A
SCHEMBL459198 0.75 AKR1B1 (0.43) AKR1B1TSHRCYP3A4LMNARECQL
SCHEMBL5164396 0.73 ACHE (0.42) TSHRCYP3A4LMNAMEN1KMT2A
SCHEMBL20738544 0.73 LMNA (0.38) TSHRLMNAPSEN1PSEN2APH1B
SCHEMBL4597897 0.71 ADRA2C (0.36) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL16954329 0.71 TRPA1 (0.33) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL18793777 0.71 ADRA2C (0.36) LMNAPSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed
WO-2012066077-A1 1,4 DI SUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2012-05-24 WO disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed